Rapid, immunoassay test for the visual, qualitative, in vitro detection of elevated levels of the MMP-9 protein in human tears, from patients suspected of having dry eye
For in vitro diagnostic use only; for prescription use; single use only
Using direct sampling microfiltration technology, InflammaDry accurately identifies elevated levels of MMP-9 protein in tear fluid samples taken from the inside lining of the lower eyelid, the palpebral conjunctiva
InflammaDry is a disposable, low cost test, that requires no additional equipment to administer or interpret results
Using four simple steps, InflammaDry test results are achieved in just 10 minutes, aiding in the diagnosis of dry eye before the patient leaves the office
InflammaDry is the first and only, rapid result, in-office test that detects elevated levels of MMP-9, an inflammatory marker that is consistently elevated in the tears of patients with dry eye disease
A CLIA Certificate of Waiver is required to perform the test in a waived setting - This test is intended for prescription use at point-of-care sites
This product is required to be reported under California Proposition 65
